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Abstract
Background: Linked to extreme rates of chronic heart and kidney disease, pyoderma is endemic amongst Aboriginal
children in Australia’s Northern Territory (NT). Many of those with pyoderma will also have scabies. We report the results of a
community-based collaboration within the East Arnhem Region, which aimed to reduce the prevalence of both skin
infections in Aboriginal children.
Methodology/Principal Findings: Commencing September 2004, we conducted an ecological study that included active
surveillance for skin infections amongst children aged ,15 years in five remote East Arnhem communities over a three year
period. Screening was undertaken by trained local community workers, usually accompanied by another project team
member, using a standard data collection form. Skin infections were diagnosed clinically with the aid of a pictorial flip chart
developed for the purpose. Topical 5% permethrin was provided for age-eligible children and all household contacts
whenever scabies was diagnosed, whilst those with pyoderma were referred to the clinic for treatment in accordance with
current guidelines. In addition, annual mass scabies treatment (5% permethrin cream) was offered to all community residents
in accordance with current guidelines but was not directly observed. Pyoderma and scabies prevalence per month was
determined from 6038 skin assessments conducted on 2329 children. Pyoderma prevalence dropped from 46.7% at baseline
to a median of 32.4% (IQR 28.9%–41.0%) during the follow-up period – an absolute reduction of 14.7% (IQR 4.7%–16.8%).
Compared to the first 18 months of observation, there was an absolute reduction in pyoderma prevalence of 18 cases per 100
children (95%CI 221.0, 216.1, p#0.001) over the last 18 months. Treatment uptake increased over the same period (absolute
difference 13.4%, 95%CI 3.3, 23.6). While scabies prevalence was unchanged, the prevalence of infected scabies (that is with
superimposed pyoderma) decreased from 3.7% (95%CI 2.4, 4.9) to 1.5% (95%CI 0.7, 2.2), a relative reduction of 59%.
Conclusion: Although pyoderma prevalence remained unacceptably high, there was a substantial reduction overall with
improvements in treatment uptake a critical factor. More acceptable alternatives, such as cotrimoxazole for pyoderma and
ivermectin as a community-wide scabicide, warrant further investigation in these settings. We are encouraged by progress
made through this work, where local action was led by local community members and primary health care providers with
external training and support.
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Introduction
Pyoderma is a generic term used to describe a clinical
diagnosis of superficial bacterial skin infection [1]. Also known
as skin sores or impetigo, it has been estimated that there are in
excess of 111 million children with pyoderma worldwide and
that many of these children will also have scabies [1]. Reported
pyoderma prevalence has varied, but children living in
Australian Aboriginal communities and those living in the
Pacific region have generally had the highest burden, often in
the range of 40–90% [2]. A recent study from Fiji [3], reported
pyoderma prevalence of 25% amongst primary school children
and 12% amongst infants. Like previous studies in remote
Australian Aboriginal communities [4,5], the Fijian study
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pyoderma and that most pyoderma was due to Group A
streptococcal (GAS) infection. Multiple GAS strains can be
present at the same time in remote Australian Aboriginal
communities, with household acquisition rates as high as 1 in 5
[6]. Whereas one or two sores would raise alarm in other
settings, the burden amongst Aboriginal children is such that
current recommendations for the Northern Territory (NT)
specify ‘‘six infected sores’’ as one of the benchmarks for
pyoderma treatment [7].
Controlling pyoderma and scabies could be an important
primary health intervention to reduce serious bacterial
infections in childhood and may have potential longer term
sequelae, particularly in relation to acute rheumatic fever
(ARF), rheumatic heart disease (RHD) and chronic kidney
disease. Pyoderma is a major underlying cause of serious
bacterial infections (GAS and Staphylococcus aureus), which are
very common in Aboriginal communities and have high
mortality [8,9]. The burden of ARF/RHD is extremely high
amongst Indigenous Australians [10]. Since GAS throat
infection is rare in this setting, it seems probable that
pyoderma (and scabies) may have a key role in the ARF/
RHD burden, although the causal pathway remains uncertain
[9,11,12]. Over the past decade: the Indigenous incidence of
end stage renal disease has been shown to be 21 times that of
non-Indigenous Australians [13]; the risk of acute post
streptococcal glomerulonephritis (APSGN) five times higher
for children with pyoderma during APSGN outbreaks [14,15];
and APSGN in childhood has been shown to substantially
increase the risk of adult renal disease [16]. Mortality from
kidney failure is also much higher than non-Indigenous
Australians [17].
Menzies School of Health Research and others have collabo-
rated with NT communities and the government authorities over
more than 10 years to develop strategies for tackling skin infections
at a community level. The initial work, which documented the link
with severe and chronic diseases, included laboratory based studies
to demonstrate that dog and human scabies were not linked [18]
and that the diverse range of streptococcal strains – including
those associated with rheumatic fever and kidney disease – are all
derived from skin infections [19]. A successful community based
scabies control program, involving annual mass treatment days for
scabies (using topical 5% permethrin cream) and active surveil-
lance for skin infections, was conducted in one of the largest
remote communities [20]. A feasibility study subsequently
demonstrated widespread support for similar programs throughout
NT Indigenous communities noting those communities that had
successfully implemented their own programs were keen to
participate in coordinated programs with related communities
[21]. We report the results of a regional collaboration involving a
number of these communities in the East Arnhem Region of the
NT where the primary aim was to reduce the prevalence of scabies
and pyoderma amongst children aged 0–14 years.
Methods
Setting and Population
The East Arnhem Healthy Skin Project (EAHSP) involved five
remote communities and associated homelands/outstations. The
total population of each community ranged from approximately
800–2000 people, encompassing a total of approximately 2600
Indigenous children aged ,15 years. Active surveillance for skin
infections was conducted over a three year period from September
2004–August 2007. Children aged ,15 years were screened for
skin infections at either the local health centre, home, in the
community or at school using a standard data collection form. We
collected additional data for a subset of children seen during
school screening, which included: appearance of pyoderma
(crusted, purulent or flat/dry), site of pyoderma (upper body or
lower body), the number of sores (,5, 5–20 or .20) and, for those
with scabies, whether or not the infestation had become infected
(scabies with a superficial bacterial skin infection = pyoderma
[1]). Screening was undertaken by trained local community
workers, usually accompanied by another project team member
(Aboriginal Health Worker, registered nurse, or visiting pediatri-
cian/dermatologist).
A formal training program was established for community
workers involving both practical ‘‘on-the-job’’ training and formal
learning packages delivered as ‘‘off-the-job’’ components. Eleven
workers completed the training program and gained recognition
against units of competency towards a Primary Health Care
qualification. The community workers, all local Aboriginal people,
were employed for up to 20 hours per week to undertake skin
screening of children and were supported every 1–2 months by a
visiting research team member.
Annual healthy skin days were held at each community,
commencing from September 2004. Coordinated by the local
community, these events included promotion of mass treatment
with scabicide cream (distributed in 30g tubes with 5%
permethrin, Lyclear H) for all community members in accordance
with current guidelines [22]. The cream was hand delivered to
each household with adequate quantities supplied for all
household members and verbal advice provided on appropriate
use of the cream. Treatment application was not directly observed
as this was not considered culturally appropriate.
Ethics Statement
The project was approved by the Human Research Ethics
Committee of the Northern Territory Department of Health
Community Services and Menzies School of Health Research
(Approval number 04/11) with written informed consent obtained
for participants.
Author Summary
Skin infections are endemic in many in remote Australian
Aboriginal communities and have been linked to very high
rates of chronic heart and kidney disease in this
population. We report the results of a regional collabora-
tion that aimed to reduce skin infections amongst children
aged less than 15 years in five remote communities. The
program included annual mass scabies treatment days
offered to all residents and routine screening/follow-up of
children. Trained community workers helped conduct over
6000 skin assessments on 2329 children over a three year
period. Of every 100 children seen at the commencement
of the study, 47 were found to have skin sores and many
had multiple sores. We demonstrate a reduction both in
the number of children with skin sores and in the severity
of those sores. On average, of every 100 children seen per
month, there were 14 fewer children with skin sores and
seven fewer children with multiple sores. Overall improve-
ment in treatment uptake was a critical factor. We found
no discernible impact against scabies. While the burden of
skin infections remains unacceptably high, we believe the
results presented here are a good news story for local
action to address a serious public health problem.
Skin Infections in Australian Aboriginal Children
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We developed two pictorial flipcharts, one to explain the
Healthy Skin Story in lay terms for study participants which
included family-based and environmental activities [23], the other
to assist in diagnosis focusing primarily on recognition and
treatment of pyoderma, scabies and tinea [24]. Both flip charts
were used by all study staff and distributed to each participating
community. Skin infections were diagnosed clinically by the
research team. Pyoderma lesions were not routinely swabbed nor
were scabies mites routinely extracted.
Treatment
Children with pyoderma were referred to the clinic for
treatment in accordance with the current guidelines [7]. If
children screened by the research team were identified with
scabies, the parent/carer was given topical 5% permethrin
(Lyclear H) to administer to the child and all household contacts.
For infants younger than 2 months of age topical Crotamiton 10%
cream was used.
Objectives and Outcomes
Given previous experience of Healthy Skin programs [4,5,20],
we expected to observe a reduction in both scabies and pyoderma
prevalence immediately following the initial mass scabicide
treatment. Our primary objective was to demonstrate reductions
in both conditions among children aged 0–14 years in the
participating communities within two years following the intro-
duction of the program:
N For scabies, we aimed to reduced prevalence from 30%
(expected pre-program) to ,10%.
N For pyoderma, we aimed to reduce prevalence from 50%
(expected pre-program) to ,25%.
A secondary objective was to reduce the severity of pyoderma
among the target group that was classified as moderate/severe
from 40% (expected pre-program) to ,15%.
Statistical Analyses
We determined the prevalence of pyoderma and scabies at
baseline as the proportion of all children seen in September 2004
(immediately preceding the initial mass community-wide scabicide
treatment). Thereafter, we determined the monthly period
prevalence of both pyoderma and scabies on the same basis,
calculated as a rolling average of all children seen over the
preceding three-month period (ie commencing from December
2004 through to August 2007). Although some children were seen
more frequently, we excluded subsequent assessments that
occurred within 30 days of the initial assessment in order to
ensure that only one assessment per individual per month was
included.
These were population level surveillance data (non-random
sample) where the intention was to screen as many children as
possible within the region given the available resources. We
monitored variation in the number of children seen over the
surveillance period by determining the median number, and
interquartile range (IQR), of children seen over each of the rolling
three-month periods. In addition, we were cognizant of the
potential that eagerness to demonstrate a benefit from a Healthy
Skin program might preferentially encourage screening of
healthier children or that awareness of the program might
conversely result in an increase in care-seeking behaviour for
those children with skin infections. We monitored this potential by
conducting an exploratory sub-analysis of pyoderma and scabies
prevalence on the first occasion that an individual subject was
seen.
We examined seasonal differences by comparing the average
monthly prevalence during the wet season (September–February)
and the dry season (March–August). We also monitored changes
over time by comparing the average monthly prevalence during
the first 18 months of the study period to that for the last 18
months using the 2 sample test of proportions as an exploratory
analysis. Data were analysed using Stata version 9 software.
Results
Number of Screening Assessments
There were 6038 skin assessments conducted on 2329 children
during the three year study period, estimated to represent 78% of
the target population (Figure 1). Most children (1245, 53.5%) were
seen once or twice, 19% three times and 28% were seen from four
to nine times. There were 583 children screened during the initial
assessment in September 2004 with a similar number (median 487,
IQR 405–578) screened over the subsequent rolling three-month
periods to August 2007 (Table 1). The median number of children
seen for the first time during the post baseline period was 132
(IQR 92–211), that is approximately 1 in 4 children seen during
the rolling 3 month periods after September 2004 had not
previously been seen. Overall, there were 2001 assessments
performed by study team members at school (33%) and 4037
(67%) elsewhere within the community (eg home or clinic).
Pyoderma and Scabies
By August 2004, there had been 2139 episodes of pyoderma
diagnosed and 807 episodes of scabies. Of the 2329 children seen,
almost all (91.8%, 95%CI 87.7,96.0) had pyoderma on at least one
occasion, while 34.7% (95%CI 31.9,37.4) had scabies on at least
one occasion. The average monthly prevalence was 35.5% for
pyoderma and 13.4% for scabies (Table 1). Pyoderma prevalence
was slightly higher amongst males, 38.8% (95%CI:37.1,40.5), than
females, 32.1% (95%CI:30.4,33.8) – an absolute difference of
Figure 1. Participation in EAHSP, September 2004–August
2007.
doi:10.1371/journal.pntd.0000554.g001
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difference in pyoderma prevalence: wet seasons=35.3%
(95%CI:33.5,37.0); dry seasons=35.8% (95%CI:34.1,37.5).
Pyoderma prevalence was similar between the three age groups.
In contrast, scabies prevalence was highest amongst children aged
,3 years and decreased with age (Table 1). Scabies prevalence
amongst children aged ,3 years (22.7%, 95% CI 20.3, 25.1) was
double that of children aged 3–14 years (11.1%, 95% CI 10.2,
12.0).
Whereas pyoderma prevalence at baseline (46.7%) was close to
expectations, scabies prevalence at baseline (16.1%) was substan-
tially lower than we expected (30%). Thereafter, we observed a
reduction in pyoderma prevalence but little if any change in
scabies prevalence. During the post baseline period, the median
monthly prevalence of pyoderma was 32.4% (IQR 28.9–41.0%) –
an absolute reduction of 14.7% (IQR 4.7–16.8%). A similar
reduction was evident when prevalence was limited to the first
time an individual child was seen – absolute reduction of 11.2%
(IQR 2.3–16.4%). In contrast, the median monthly prevalence of
scabies remained similar at 13.1% (IQR 11.7–15.9) – a marginal
absolute reduction of 3.0% (IQR 0.2–4.4%), with no discernible
difference in the median monthly prevalence when limited to
children seen for the first time during the post baseline period
(Table 1).
Bothpyodermaandscabiesprevalencevariedovertime(Figure2)
but these did not closely correspond to annual mass scabicide
treatment, which occurred in September 2004, September 2005
and September–October 2006. Whereas scabies prevalence fluctu-
ated close to the baseline rate over the three year study period,
pyoderma prevalence was notably lower over the latter 18 month
period (Figure 2). For scabies, the pattern was similar when data
were limited to prevalence determined amongst those children who
were seen for the first time (Figure 3). In contrast, pyoderma
prevalence amongst this subgroup of children actually increased
towards the end of the observation period suggesting that these
children were more likely to be diagnosed with pyoderma but were
not more likely to be diagnosed with scabies.
The reduction in pyoderma prevalence over the latter 18 month
period was evident across all age groups (Figure 4), whereas there
was no evidence of a comparable reduction in scabies prevalence.
During the latter 18 month period, there were 18 fewer pyoderma
cases for every 100 children seen (95%CI:221.0,216.1, p,0.001),
a 40% reduction when compared to rates during the first 18
month period. The greatest absolute reduction was amongst
children aged 3–14 years: 20 fewer cases of pyoderma for every
100 children seen (220.3%, 95%CI:223.0,217.6).
We collected additional data for children seen during school
screening (n=2001 aged 3–14 years). For this subset of children,
pyoderma prevalence was 40.2% (95%CI 38.1,42.4), slightly
higher than that of children in the same age group who were seen
outside the school setting (33.2%, 95%CI 31.8,34.7). For children
seen during school screening, pyoderma was most commonly
diagnosed on the legs (Table 2) where 36.5% of children had lower
body pyoderma compared with 17.6% upper body pyoderma.
Multiple sores (five or more) were also more common on the lower
body (14.2%) than the upper body (4.5%). Of those school
children with pyoderma, 88.1% (95%CI: 85.7,90.4) had sores on
the lower body while 42.4% (95%CI:38.9,45.9) had sores on the
upper body. The lower body was the region where the reduction
in prevalence was most evident: 13 fewer cases of lower body
pyoderma per 100 children seen and 6 fewer cases of children with
multiple lower body sores (Table 2). There was also a reduction in
the nature of the sores, with 10 fewer cases of crusted/purulent
pyoderma per 100 children seen during the latter 18 month
period.
From the additional data collected, we identified 144 children
who had been diagnosed with five or more pyoderma lesions. Of
these, only 50 (34.7%) were recommended for treatment – the vast
bulk, 94 (65.3%) had no treatment follow-up. We reviewed clinic
records for those who had been referred for treatment. While
treatment uptake remained low, there was a substantial improve-
ment during the latter 18 month period when 17.2% of children
with five or more sores received treatment, single dose benzathine
penicillin, compared to 3.8% during the initial 18 month period
Table 1. Population-based screening for pyoderma and scabies among children aged ,15 years, East Arnhem Region, September
2004–August 2007.
Pyoderma Scabies
n % (95% CI) n % (95% CI)
Children screened for skin condition
a 2323 n/a 2321 n/a
Average monthly prevalence all ages
b 6018 35.5% (34.3,36.8) 6026 13.4% (12.5,14.3)
Aged ,3 yrs 1192 35.6% (32.9,38.3) 1198 22.7% (20.3,25.1)
Aged 3-,9 yrs 2925 39.8% (38.1,41.6) 2925 13.3% (12.1,14.6)
Aged 9–14 yrs incl 1901 28.9% (26.9,31.0) 1903 7.6%, (6.4,8.8)
Median monthly prevalence n % (IQR) % % (IQR)
September 2004 (Baseline) 582 45.7% 583 16.1%
October 2004–August 2007 (all assessments)
c 487 32.4% (28.9–41.0) 487 13.1% (11.7–15.9)
October 2004–August 2007 (1
st assessment)
d 132 34.5% (29.3–43.4) 132 15.8% (12.9–19.4)
a‘‘n’’ refers to the number of children seen. In total, there were 2329 children for whom skin assessments undertaken, 6 children (0.3%) had data missing on pyoderma
status and 8 children (0.3%) had data missing on scabies status.
b‘‘n’’ refers to the number of skin assessments undertaken. In total, there were 6038 skin assessments undertaken on 2329 children with 1084 children seen more than
once (range 2–9 times). Twenty assessments (0.3%) had data missing on pyoderma status, and 12 (0.2%) on scabies status.
c‘‘n’’ refers to the median number of children screened during rolling 3 month periods from October 2004–August 2007 (ie 33 consecutive periods). The interquartile
range was 405–578 for pyoderma and 405–580 for scabies.
d‘‘n’’ refers to the median number of children screened for the first time during rolling 3 month periods from October 2004–August 2007 (ie 33 consecutive periods). The
interquartile range for the first assessment was 92–211 for pyoderma and for scabies.
doi:10.1371/journal.pntd.0000554.t001
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through community based surveillance for the East Arnhem Healthy Skin Project from September 2004–August 2007.
doi:10.1371/journal.pntd.0000554.g003
Figure 2. Pyoderma and scabies among children aged ,15 years. n=6038 assessments conducted through community based surveillance
for the East Arnhem Healthy Skin Project from September 2004–August 2007.
doi:10.1371/journal.pntd.0000554.g002
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increase in treatment uptake equivalent to 13 children per 100
seen (95%CI 3.3,23.6). By comparison, although there was an
overall reduction in crusted or purulent pyoderma (10%) there was
not a demonstrable increase in treatment uptake for these children
(3.5%, 95%CI 20.7,7.6).
Figure 4. Average monthly prevalence of pyoderma and scabies by age group and month of screening. n=6038 assessments
conducted through community based surveillance for the East Arnhem Healthy Skin Project from September 2004–August 2007.
doi:10.1371/journal.pntd.0000554.g004
Table 2. Average monthly prevalence of pyoderma and scabies, EAHSP, September 2004–August 2007.
Sep04–Feb06
(18 months) % (95%CI)
Mar06–Aug07




All ages 46.0 (44.1,48.0) 27.5 (26.0,29.0) 218.5 (221.0,216.1) ,0.001
Aged ,3 yrs 41.7 (37.7,45.8) 30.0 (26.4,33.6) 211.8 (217.2,26.3) ,0.001
Aged 3-,9 yrs 51.1 (48.4,53.9) 31.6 (29.4,33.8) 219.5 (223.1,216.0) ,0.001
Aged 9–14 yrs incl 41.3 (37.9,44.7) 19.7 (17.4,22.1) 221.6 (225.7,217.5) ,0.001
Additional data*
Upper body pyoderma* 22.7 (19.8,25.6) 13.5 (11.4,15.6) 29.2 (212.8,25.7) ,0.001
Lower body pyoderma* 44.1 (40.7,47.5) 30.4 (27.6,33.2) 213.7 (218.1,29.3) ,0.001
Upper body 5 or more sores 5.2 (3.6,6.7) 4.0 (2.8,5.2) 21.2 (23.2,0.7) 0.2
Lower body 5 or more sores 17.8 (15.1,20.5) 11.5 (9.5,13.5) 6.3 (29.6,22.9) ,0.001
5 or more sores* 19.9 (17.2,22.7) 12.6 (10.6,14.7) 27.3 (23.9,210.8) ,0.001
Treatment for those with 5+ sores* 3.8 (20.4, 7.9) 17.2 (8.0,26.4) 13.4 (3.3,23.6) 0.007
Crusted/purulent pyoderma* 31.6 (28.4,35.8) 21.6 (19.0,24.1) 210.0 (214.1,26.0) ,0.001
Treatment for crusted/purulent pyoderma* 3.9 (1.5,6.2) 7.3 (3.9,10.8) 3.5 (20.7,7.6) 0.1
Scabies
All ages 14.3 (13.0,15.7) 12.7 (11.6,13.8) 21.7 (23.4,0.1) 0.06
Aged ,3 yrs 22.6 (19.2,26.0) 22.8 (19.5,26.1) 0.2 (24.5,5.0) 0.9
Aged 3-,9 yrs 13.7 (11.8,15.7) 13.0 (11.4,14.6) 20.7 (23.2,1.8) 0.6
Aged 9–14 yrs incl 9.4 (7.4,11.4) 6.3 (4.9,7.8) 23.1 (25.5,20.6) 0.01
Additional data*
Infected scabies* 3.7 (2.4,4.9) 1.5 (0.7,2.2) 22.2 (23.7,20.7) 0.003
Notes: ‘‘Absolutedifference’’ refersto the difference in the average monthlyprevalenceinthefirst18months(Sep04–Feb06)comparedtothesecond 18 months (Mar06–Aug07).
*indicates parameters for which comparable data were sought on 2001 children seen during school screening (age 3–14 years).
doi:10.1371/journal.pntd.0000554.t002
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latter 18 month study period (Figure 4), there was a significant
reduction in prevalence of infected scabies amongst children aged
3–14 years, falling from 3.7% (95% CI 2.4,4.9) of children seen in
the first 18 months to 1.5% (95% CI 0.7,2.2) in the last 18 months
(Table 2). Comparable data were not routinely collected over the
entire study period for children aged less than 3 years.
Discussion
Our data suggests regular surveillance and routine service
delivery can have an impact on pyoderma prevalence, indepen-
dent of a reduction in scabies prevalence, and that the reduction in
pyoderma prevalence is probably due to increased adherence to
antibiotic treatment regimens. This study was a collaboration
between local people in remote Aboriginal communities of
northern Australia, staff at the primary health care clinic,
researchers and other health specialists. The concept for a regional
approach was built on a history of more than a decade of work
aimed at tackling skin infections at the community level [4,20].
Our expectation was that mass community treatment for scabies
would provide the impetus to reduce skin infections. This had been
the experience previously, where reductions in scabies prevalence
had been accompanied by reductions in pyoderma prevalence,
predominantly of the upper body [4,5]. In contrast, we found no
evidence of an overall impact on scabies prevalence but a
substantial reduction in pyoderma prevalence, predominantly
(but not limited to) the lower body. These data were supported by
evidence of increased treatment uptake for children with five or
more sores and a trend towards increased treatment uptake for
those with crusted or purulent sores.
While the data need to be considered with caution (as discussed
later), it is encouraging to note that there was a reduction in the
observed pyoderma prevalence over the study period. Compared
to the initial screening in September 2004, the median prevalence
in the post baseline period was equivalent to 14 fewer cases of
pyoderma per 100 children seen (IQR 4.7–16.8). When the
baseline period was extended to include the first 18 months of
observation (September 2004–February 2006), the reduction over
the following 18 month period was equivalent to 18 fewer cases of
pyoderma per 100 children seen (95%CI 16,21). The reduction
was observed across all age groups and, where data were available,
was also seen across both lower and upper body sites, there were
fewer children with multiple sores and fewer children with
crusted/purulent pyoderma. We saw no overall reduction in
scabies prevalence but there was a reduction in the proportion
with infected scabies. Overall, these data are most consistent with
a pyoderma treatment effect than an underlying reduction in
scabies prevalence.
We have been encouraged by a model of outreach service that
evolved during the study incorporating locally trained community
workers at the front-line, well supported by local health service
providers and community leaders. The increased surveillance of
skin infections that was provided by the community workers,
which included home visits, was beyond the current capacity/
usual practice of local health-care clinics. The subsequent decline
in pyoderma highlights the benefits of such a service for both
community members and health services given the high workload
generated by skin infections.
Although we are encouraged by the apparent decrease, the
pyoderma burden remains unacceptably high, affecting in excess
of 25 children out of every 100 seen each month for the last year of
the study. In related work undertaken in two of the participating
communities, we found that 50% of children presented to a
primary health care clinic between 10 and 22 times per child per
year and that almost 1 in 5 of these presentations (18%) were for
skin infections [25]. Most children reached their first birthday
having had an episode of pyoderma (69%) and scabies (63%), with
most having their first episode diagnosed at just 2 months of age
[25]. Previous work in a similar setting has shown secondary
transmission of GAS within the household to be as high as 19%
[6].
Pyoderma prevalence has ranged from 10–70% in other studies
[4,5]. Wong et al administered intramuscular benzathine penicillin
at the initial diagnosis and again at follow up visits [20]; non-
scabies pyoderma reduced from 11% to 3% within three months
but returned to pre-intervention rates by nine months. In our
study, pyoderma treatment was by referral to the primary health
care clinic. We saw no evidence of a reduction during the initial 18
month period then observed a sustained reduction in pyoderma
prevalence over the ensuing 18 month period.
Given the high endemicity of pyoderma in remote Indigenous
communities, there may well be a tendency for multiple sores to be
seen as the norm rather than being a serious condition requiring
treatment. This seems to be reflected in current guidelines for the
area that recommend treatment where there are ‘‘six infected
sores’’ or the sores ‘‘look severe’’ [7]. In our view, the threshold for
pyoderma treatment has been raised too high. Our data support
this concern. Of 1818 children from whom data were recorded on
the number of sores, we found 1 in every 6 children screened
(16%) had multiple sores but (even though treatment uptake
improved) very few ultimately received that treatment. Clearly,
appropriate treatment of children with severe pyoderma is an area
with substantial scope for improvement. Overall, treatment uptake
remained sub-optimal but we were encouraged by the improve-
ment in pyoderma treatment rates during the latter 18 month
period and suspect that this may have contributed to the reduction
in prevalence. Low treatment uptake rates and the emerging issue
of community-associated methicillin-resistant Staphylococcus aureus
in Indigenous populations [26], highlight the need to investigate
alternatives to benzathine penicillin for pyoderma treatment.
Scabies prevalence in our study was lower than previously
published data [4], but still substantial - particularly for younger
children where the monthly period prevalence was 23% for those
aged ,3 years. In contrast to other settings where community-
wide use of scabicides has reduced scabies prevalence [5,20,27], it
is apparent that household scabicide use within our communities
has been poor. In a nested study, La Vincente et al found only
44% of household contacts of scabies cases used the permethrin
cream [28]. Given that those households where all contacts had
used the cream were six times less likely to have ongoing scabies
transmission [28], low levels of household treatment uptake
appears the most likely explanation for the lack of a discernible
impact against scabies prevalence. We acknowledge that permeth-
rin resistance is of concern [29], however the findings of the nested
study by La Vincente et al suggest the issue is primarily related to
non-use of the cream rather than a failure of cream itself.
Alternative treatment regimes, in particular the role of oral
ivermectin in older children and household contacts [30,31],
warrants further investigation in this setting. Licensed to treat
onchocerciasis and strongyloidiasis, ivermectin has also been
approved for treatment of refractory crusted scabies cases in
Australia but is not currently approved for treatment of ‘ordinary’
scabies cases and their contacts [32].
Determining the denominator for a prospective study such as
ours is problematic as there can be considerable population
movement between communities over time. We also acknowledge
the potential bias in care-seeking/screening seeking behaviour and
Skin Infections in Australian Aboriginal Children
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However, given that scabies and pyoderma are so frequently
identified as co-infections in children, it would seem unlikely that
bias or confounding could explain why prevalence of the former
would be unchanged while the latter reduced substantially.
Conclusions
Sub standard living conditions are common factors reported in
many communities where skin infections are endemic [33,34].
Redressing inadequate living conditions, poverty and other social
determinants of health are major priorities for long term health
benefits for Indigenous Australians. For skin infections, a reduction
in pyoderma prevalence is the primary priority and the most
encouraging outcome from our study. In our view, increased
treatment uptake is the most likely explanation but we believe it
has been local action delivered through basic primary health
services that has been the driver.
Surveillance for skin infections, supported by appropriate
treatment where indicated, can reduce pyoderma prevalence.
Local community workers played a key role in the surveillance
component but more work is needed in improving treatment
uptake, both in terms of the threshold for treatment referral and
perhaps also in regards to a more effective alternative to
benzathine penicillin. We are currently investigating the role of
cotrimoxazole in this regard. Although we found no discernible
impact against scabies, we know that reducing scabies prevalence
will further reduce pyoderma prevalence. The potential for oral
ivermectin as a more acceptable alternative to community-wide
use of scabicide cream, particularly for adult household contacts,
needs to be investigated amongst Indigenous populations where
scabies continues to be endemic.
Like most people living in remote Indigenous communities, as
well as those working in primary health care, we acknowledge that
much still needs to be done. However, on balance, we believe the
results presented here are a good news story for local action to
address a serious public health problem.
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